You are on page 1of 3

CODE : AD/AE -E – 6.

1
IMPLEMENTATION DATE:
DEPARTEMENT OF MASTER &RESEARCH
01/ 01/2014
REVISION DATE:
01/01/2017
“New trends in pharmaceutical industry”: Final
Evaluation
PAGE 1 TO
EDITION 1
1

Year : 2022 – 2023 Academic year : M2Pro

Semester: Second Partial Final

Professor name: Dr. Roula Ajrouche


Total number of pages: 2 Deadline: July 4 2023

Instructions for students:


1-This examination paper contains 2 parts
2-This exam is rated over 20
3-All references should be mentionned

Student Name :

Good Luck

1
Part I: Summarize GMP recommendations for biological products in max 2-5 pages
(Text, table, Figure, etc..) based on WHO report. This summary should include
recommendations related to:
1- Personnel
2- Starting materials
3- Seed lots and cell banks
4- Premises and equipment
5- Containment
6- Clean rooms
7- Production
8- Labelling
9- Validation
10- Quality control
(10 pts)

Part II: Regarding each viral disease, each student should specify
-All specialties of vaccines with prices and country of origin (2 pts)
-The year of licensure (1 pt)
-Number of serotypes covered by vaccine with type of vaccine (inactivated, live
attenuated, virus like particles, etc…) and technology required (cell culture, egg culture,
etc…) (3 pts)
-Age of vaccination and doses needed (2 pts)
-Form, Route and presentation (2 pts)
NB: All references should be mentioned

Disease
Yara abou Mansour Yellow Fever
Mohammad harakeh Smallpox
Zahraa ali atoui Influenza A and B
Lucie alojeil Poliovirus
Kamal morkos Measles
Mariam fadel Mumps
Sara majzoub Rubella
Tala salman Rabies
Selina Ghazawi Adenovirus
Jad Sidani Hepatitis B
Anan Eissa Japanese encephalitis
Nourman Saadie Hepatitis A
Zeina Kassem Varicella
Kawkab Khalil Rotavirus
Mohammad Khalil Human papillomavirus
Nisreen Ghanem Dengue
Rayane rizk Hepatitis E

Kassem Hijazi Zoster

Michal Moubarak Ebola

Lama Mortada Diphteria

Nour Nehme Tetanos

Rola nasser Pneumococcal

Ali khalaf Meningiococcal

2
Nuha Hammoud Coronavirus

You might also like